Edition:
United States

Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

22.61USD
29 Sep 2016
Change (% chg)

-- (--)
Prev Close
$22.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
67,363
52-wk High
$25.30
52-wk Low
$13.38

FMI.OQ

Chart for FMI.OQ

About

Foundation Medicine, Inc. is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. The Company's segment is the business of delivering molecular information about cancer to its customers. Its products provide genomic... (more)

Overall

Beta: --
Market Cap(Mil.): $789.71
Shares Outstanding(Mil.): 34.93
Dividend: --
Yield (%): --

Financials

  FMI.OQ Industry Sector
P/E (TTM): -- 44.84 37.54
EPS (TTM): -2.49 -- --
ROI: -32.45 -0.27 13.98
ROE: -33.75 -2.93 14.88

BRIEF-Epizyme collaborates with Foundation Medicine for tazemetostat phase 2 clinical trial

* Epizyme establishes collaboration with Foundation Medicine to support tazemetostat phase 2 clinical trial

Sep 21 2016

BRIEF-Foundation Medicine Inc - FoundationOne accepted by FDA and CMS for Parallel Review and FDA Expedited Access Pathway

* FoundationOne accepted by FDA and CMS for parallel review and FDA expedited access pathway

Aug 02 2016

BRIEF-Foundation Medicine Q1 revenue $30.4 mln

* Foundation medicine announces 2016 first quarter results and recent highlights

May 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.